The Use of Drugs for Cardioversion of Recent Onset Atrial Fibrillation and FlutterFocus on Ibutilide

被引:0
|
作者
Owen A. Obel
A. John Camm
机构
[1] St George’s Hospital Medical School,Department of Cardiological Sciences
来源
Drugs & Aging | 1998年 / 12卷
关键词
Atrial Fibrillation; Adis International Limited; Amiodarone; Sinus Rhythm; Flecainide;
D O I
暂无
中图分类号
学科分类号
摘要
Atrial fibrillation (AF) is the most common sustained arrhythmia, particularly in the elderly population. It is well recognised that AF is a major cause of stroke, even in the absence of underlying heart disease. Although AF and atrial flutter share many causes and may be seen in the same patient, there are differences between these arrhythmias: atrial flutter is less common, and the risk of stroke associated with it is less than that with AF. In addition to stroke, both AF and atrial flutter may cause cardiomyopathy, which may be fully reversible with effective treatment of the arrhythmia. Both AF and atrial flutter can result in severe symptoms and may precipitate heart failure, ischaemia and syncope. Recent research indicates that AF is a self-perpetuating arrhythmia, and that the longer it is left untreated the less likely it is that effective cardioversion will be possible.
引用
收藏
页码:461 / 476
页数:15
相关论文
共 50 条
  • [1] Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset
    Reisinger, J
    Gatterer, E
    Lang, W
    Vanicek, T
    Eisserer, G
    Bachleitner, T
    Niemeth, C
    Aicher, F
    Grander, W
    Heinze, G
    Kühn, P
    Siostrzonek, P
    EUROPEAN HEART JOURNAL, 2004, 25 (15) : 1318 - 1324
  • [2] Cardioversion in recent onset atrial fibrillation
    Fernandez de Simon, Amparo
    Coll-Vinent, Blanca
    Martin, Alfonso
    Suero, Coral
    Sanchez, Juan
    Varona, Mercedes
    Sanchez, Susana
    Cancio, Manuel
    Carbajosa, Jose
    Malagon, Francisco
    Montull, Eugeni
    del Arco, Carmen
    EMERGENCIAS, 2019, 31 (04): : 227 - 233
  • [3] Safety and Efficacy of Ibutilide in Cardioversion of Atrial Flutter and Fibrillation
    Nair, Madhuri
    George, Lekha K.
    Koshy, Santhosh K. G.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2011, 24 (01) : 86 - 92
  • [4] Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation
    Tampieri, Andrea
    Rusconi, Anna Maria
    Lenzi, Tiziano
    INTERNAL AND EMERGENCY MEDICINE, 2012, 7 : S241 - S250
  • [5] Safety and Efficacy of Ibutilide for Acute Pharmacological Cardioversion of Rheumatic Atrial Fibrillation
    Shenthar, Jayaprakash
    Banavalikar, Bharatraj
    Valappil, Sanjai Pattu
    Deshpande, Saurabh
    Nireshwalia, Aparna
    Padmanabhan, Deepak
    Reddy, Sathish S.
    CARDIOLOGY, 2021, 146 (05) : 624 - 632
  • [6] Vernakalant Use in Cardioversion of Recent Onset Atrial Fibrillation: A Case Report
    Nikovic, Vuk
    Blagojevic, Predrag
    Milenkovic, Dusan
    Laggner, Anton
    Domanovits, Hans
    Bulajic, Ranka
    ACTA FACULTATIS MEDICAE NAISSENSIS, 2018, 35 (03) : 256 - 261
  • [7] Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation
    Khan, IA
    Mehta, NJ
    Gowda, RM
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 89 (2-3) : 239 - 248
  • [8] Single High Oral Dose Amiodarone for Cardioversion of Recent Onset Atrial Fibrillation
    Nadarasa, Kugathasan
    Williams, Michael J. A.
    HEART LUNG AND CIRCULATION, 2012, 21 (08): : 444 - 448
  • [9] Gender Differences With Ibutilide Effectiveness and Safety in Cardioversion of Atrial Fibrillation
    Malkoc, Aldin
    Phan, Alexander
    Falatoonzadeh, Payam
    Mac, Olivia
    Sherman, William
    Wong, David T.
    JOURNAL OF SURGICAL RESEARCH, 2024, 296 : 10 - 17
  • [10] Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation
    Vogiatzis, I
    Papavasiliou, E.
    Dapcevitch, I
    Pittas, S.
    Koulouris, E.
    HIPPOKRATIA, 2017, 21 (02) : 67 - 73